NE Bodycare Aps

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  2.6% 2.6% 22.6% 17.1% 12.7%  
Credit score (0-100)  63 61 3 9 17  
Credit rating  BBB BBB B BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  178 178 90.7 -54.1 31.2  
EBITDA  178 178 90.7 -54.1 31.2  
EBIT  149 149 -56.4 -54.1 31.2  
Pre-tax profit (PTP)  98.0 98.0 -103.9 -57.6 10.1  
Net earnings  76.2 76.2 -152.4 -57.6 10.1  
Pre-tax profit without non-rec. items  98.0 98.0 -104 -57.6 10.1  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  3,319 3,319 0.0 0.0 0.0  
Shareholders equity total  687 687 -65.2 -123 -113  
Interest-bearing liabilities  2,122 2,122 0.0 0.0 0.0  
Balance sheet total (assets)  3,432 3,432 450 385 418  

Net Debt  2,101 2,101 -446 -378 -411  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  178 178 90.7 -54.1 31.2  
Gross profit growth  -7.6% 0.0% -49.2% 0.0% 0.0%  
Employees  0 0 2 2 2  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  3,432 3,432 450 385 418  
Balance sheet change%  -3.3% 0.0% -86.9% -14.4% 8.4%  
Added value  178.3 178.3 90.7 93.0 31.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  -89 -30 -3,466 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  4.0 5.0 -1.0 -2.0 1.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  83.3% 83.3% -62.2% 100.0% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  4.3% 4.3% -2.9% -10.6% 6.0%  
ROI %  4.8% 5.3% -4.0% 0.0% 0.0%  
ROE %  12.8% 11.1% -26.8% -13.8% 2.5%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  20.2% 20.2% -12.7% -24.2% -21.3%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  1,178.1% 1,178.1% -491.4% 698.8% -1,318.7%  
Gearing %  308.8% 308.8% 0.0% 0.0% 0.0%  
Net interest  0 0 0 0 0  
Financing costs %  2.2% 2.4% 4.5% 0.0% 0.0%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.2 0.2 0.9 0.8 0.8  
Current Ratio  0.1 0.1 0.9 0.8 0.8  
Cash and cash equivalent  21.0 21.0 445.5 378.2 410.8  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -659.9 -659.9 -65.2 -122.9 -112.8  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 45 46 16  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 45 -27 16  
EBIT / employee  0 0 -28 -27 16  
Net earnings / employee  0 0 -76 -29 5